Cullinan Therapeutics, Inc.
CGEM
$16.33
$0.181.12%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 15.82% | -5.28% | -42.47% | -59.93% | -29.83% |
| Total Receivables | -- | -5.67% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -52.51% | -52.49% | -30.96% | -31.85% | 9.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.73% | -6.73% | -42.19% | -59.29% | -28.71% |
|
|
|||||
| Total Current Assets | 13.73% | -6.73% | -42.19% | -59.29% | -28.71% |
| Net Property, Plant & Equipment | 28.84% | 29.83% | -44.76% | -40.85% | -33.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -18.85% | -18.85% | -21.52% | -20.22% | -20.43% |
| Total Assets | -30.48% | -27.89% | -25.89% | -23.62% | 28.98% |
|
|
|||||
| Total Accounts Payable | -26.23% | -50.00% | -18.58% | 58.26% | -8.25% |
| Total Accrued Expenses | 54.34% | 33.93% | 48.16% | 18.84% | 28.86% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -46.18% | -40.09% | -5.56% | 14.73% | 1.35% |
| Total Finance Division Other Current Liabilities | -51.63% | -30.69% | -11.35% | 0.63% | 84.00% |
| Total Other Current Liabilities | -51.63% | -30.69% | -11.35% | 0.63% | 84.00% |
| Total Current Liabilities | 28.54% | 23.15% | 35.34% | 19.52% | 24.74% |
|
|
|||||
| Total Current Liabilities | 28.54% | 23.15% | 35.34% | 19.52% | 24.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 236.31% | 124.15% | -- | -91.77% | -73.21% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.22% | 25.87% | 29.01% | 12.75% | 17.16% |
|
|
|||||
| Common Stock & APIC | 3.69% | 3.87% | 4.26% | 4.44% | 45.79% |
| Retained Earnings | -53.04% | -59.71% | -67.63% | -73.84% | -75.10% |
| Treasury Stock & Other | -74.85% | 866.92% | 0.31% | 227.52% | 252.57% |
| Total Common Equity | -33.65% | -30.76% | -28.11% | -25.00% | 29.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -33.65% | -30.76% | -28.11% | -25.00% | 29.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -33.65% | -30.76% | -28.11% | -25.00% | 29.64% |
|
|
|||||